Email this article ROLE OF CYTOKINE ACTIVATION IN THE DEVELOPMENT OF CARDIOVASCULARDISORDERS IN PATIENT WITH GRAVES DISEASE AND CHRONIC HEART FAILURE
- Authors: Frolova AV1, Rodionova TI1
-
Affiliations:
- Saratov State medical university named after V.I. Razumovsky
- Issue: Vol 7, No 2 (2015)
- Pages: 74-77
- Section: Reviews
- URL: https://journals.eco-vector.com/vszgmu/article/view/8488
- DOI: https://doi.org/10.17816/mechnikov20157274-77
- ID: 8488
Cite item
Open Access
Access granted
Abstract
The aim of the study is to assess the ability to influence immunological changes on the formation of cardiovascular complications of hyperthyroidism by determining the level of thyrotropin-receptor antibodies (TRAb), 6,8,10 interleukins (IL-6,8,10) and tumor necrosis factor-alpha (TNF-) in patients with Graves’ disease (Gd) and chronic heart failure (CHF) and without it. 68 patients were investigated with Gd, CHF diagnosed in 38 patients (55.9%), stage 1- in 12 patients (31.6%), stage 2A - in 19 (50%) patients, stage 2B - in 7 (18,4%) patients. For the analysis, patients were divided into 3 groups: 1 - with no signs of heart failure, 2 with CHF 1 stage (because the clinical signs characteristic of heart failure stage 1 can also be symptoms of hyperthyroidism, these patients were in separate group), 3 - CHF 2A and step 2B. In all three patients groups showed a significant increase in the levels of cytokines and TRAb compared with the control group. The development of CHF in patients with Graves’ disease is associated with increasing of IL-6, IL-8 and IL-10 concentration. direct correlation between the level of TRAb, TNF- and development of the cardiovascular complications in patients with Gd have not been identified.
Full Text
About the authors
A V Frolova
Saratov State medical university named after V.I. Razumovsky
T I Rodionova
Saratov State medical university named after V.I. Razumovsky
References
- Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis // Endocrine Practice. - 2011. - №17 - P. 520.
- Эндокринология: Руководство для врачей / В.В. Потемкин [ и др.]. - М.: ООО "Медицинской информационное агентство", 2013. - 776с.
- Иммунология / под ред. Ройтта А., Бростоффа Дж., Дейла Д.; пер. с англ.- М.: «Логосфера», 2007 - 568с.
- Esfahanian F., Naimi E., Doroodgar F. et al. Th1/Th2 Cytokines in Patients with Graves' Disease with or without Ophthalmopathy // Iran J. Allergy Asthma Immunol. - 2013. -12(2) - P.168-175.
- Michels AW, Eisenbarth GS. Immunologic endocrine disorders // J Allergy Clin Immunol. - 2010. - 125(2). - 226-237.
- Lumachi F, Basso SM, Orlando R. Cytokines, thyroid diseases and thyroid cancer // Cytokine. - 2010. - 50(3). - P. 229-33.
- Салихова А.В., Фархутдинова Л.М. О роли иммунной системы в развитии кардиоваскулярных нарушений при диффузном токсическом зобе // Цитокины и воспаление. - 2013. - N3. - С. 18-20.
- Серебрякова О.В. Патогенетические механизмы формирования кардиомиопатии при тиреотоксикозе и гипотиреозе. Автореферат на соискание ученой степени доктора медицинских наук. Чита, 2008.
- Латогуз И.К., Зимина М.С. Активность цитокинов при тиреотоксической кардиомиопатии // Врач. - 2005. - N2. - С. 23-26.
- Гома Т.В., Хамнуева Л.Ю., Орлова Г.М. Клинико-иммунологические аспекты поражения сердечно-сосудистой системы у больных с болезнью Грейвса и хронической сердечной недостаточностью // Клиническая и экспериментальная тиреоидология. - 2011. - том 7, №3. - С.42-47.
- Эндокринология. Национальное руководство / под ред. И. И. Дедова, Г. А. Мельниченко. - М.: ГЭОТАР-Медиа, 2013. - 1084 с.
Supplementary files
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).